Loncar Cancer Immunotherapy ETF (CNCR)

$15.77 2.40% $0.37

The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index. The fund is non-diversified.

$13.36M

Oct 13, 2015

$0.00

0.00

0.00

21.98%

0.00%

0.00

0.00

0.00

0.00

0.00%

0.00%

Sector weights (11)

Health Care Select Sector SPDR Fund

XLV

100%

$155.92 0.36%
Uptrend

Utilities Select Sector SPDR Fund

XLU

0%

$78.01 -0.60%
Uptrend

Technology Select Sector SPDR Fund

XLK

0%

$223.62 2.97%
Neutral

The Real Estate Select Sector SPDR Fund

XLRE

0%

$44.76 -0.25%
Uptrend

Industrial Select Sector SPDR Fund

XLI

0%

$134.12 1.72%
Uptrend

Financial Select Sector SPDR Fund

XLF

0%

$45.69 1.11%
Uptrend

Energy Select Sector SPDR Fund

XLE

0%

$88.98 1.22%
Downtrend

Consumer Staples Select Sector SPDR Fund

XLP

0%

$82.65 -0.59%
Uptrend

Consumer Discretionary Select Sector SPDR Fund

XLY

0%

$197.14 2.28%
Uptrend

Communication Services Select Sector SPDR Fund

XLC

0%

$88.90 1.36%
Uptrend

Materials Select Sector SPDR Fund

XLB

0%

$94.74 1.51%
Uptrend

ETF Constituents (20)

Instil Bio, Inc.

TIL

3.591%

$58.75 -11.12%
Uptrend

Replimune Group, Inc.

REPL

3.541%

$11.23 1.35%
Uptrend

Iovance Biotherapeutics, Inc.

IOVA

3.471%

$10.35 1.77%
Downtrend

Bristol-Myers Squibb Company

BMY

3.391%

$49.02 -1.45%
Neutral

Nektar Therapeutics

NKTR

3.371%

$1.27 0.79%
Neutral

Merck & Co., Inc.

MRK

3.371%

$117.23 -1.19%
Downtrend

Regeneron Pharmaceuticals, Inc.

REGN

3.361%

$1,150.19 1.00%
Uptrend

Gilead Sciences, Inc.

GILD

3.331%

$83.90 0.01%
Uptrend

Fate Therapeutics, Inc.

FATE

3.331%

$4.00 3.09%
Downtrend

Arcus Biosciences, Inc.

RCUS

3.321%

$16.80 1.88%
Downtrend

Atara Biotherapeutics, Inc.

ATRA

3.301%

$7.93 0.76%
Downtrend

Allogene Therapeutics, Inc.

ALLO

3.291%

$2.91 1.04%
Downtrend

ImmunityBio, Inc.

IBRX

3.281%

$3.48 1.75%
Downtrend

bluebird bio, Inc.

BLUE

3.281%

$0.49 -0.61%
Downtrend

Shattuck Labs, Inc.

STTK

3.231%

$3.70 1.37%
Downtrend

IGM Biosciences, Inc.

IGMS

3.231%

$17.23 3.48%
Uptrend

ALX Oncology Holdings Inc.

ALXO

3.211%

$2.17 1.40%
Downtrend

Legend Biotech Corporation

LEGN

3.201%

$50.83 1.84%
Downtrend

BeiGene, Ltd.

BGNE

3.191%

$198.59 0.66%
Uptrend

MacroGenics, Inc.

MGNX

3.171%

$3.39 2.73%
Downtrend